Centene Current Ratio 2012-2026 | CNC
Current and historical current ratio for Centene (CNC) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Centene current ratio for the three months ending March 31, 2026 was 0.00.
| Centene Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-03-31 | $21.26B | $16.83B | 1.26 |
| 2025-12-31 | $17.89B | $13.77B | 1.30 |
| 2025-09-30 | $44.06B | $40.63B | 1.08 |
| 2025-06-30 | $40.39B | $36.79B | 1.10 |
| 2025-03-31 | $41.29B | $37.14B | 1.11 |
| 2024-12-31 | $38.00B | $34.26B | 1.11 |
| 2024-09-30 | $37.41B | $34.06B | 1.10 |
| 2024-06-30 | $38.41B | $32.73B | 1.17 |
| 2024-03-31 | $38.45B | $32.78B | 1.17 |
| 2023-12-31 | $40.76B | $36.72B | 1.11 |
| 2023-09-30 | $41.41B | $36.85B | 1.12 |
| 2023-06-30 | $34.87B | $31.31B | 1.11 |
| 2023-03-31 | $35.01B | $32.86B | 1.07 |
| 2022-12-31 | $30.13B | $28.46B | 1.06 |
| 2022-09-30 | $33.28B | $31.33B | 1.06 |
| 2022-06-30 | $32.41B | $29.09B | 1.11 |
| 2022-03-31 | $31.11B | $29.69B | 1.05 |
| 2021-12-31 | $28.50B | $25.77B | 1.11 |
| 2021-09-30 | $28.06B | $25.04B | 1.12 |
| 2021-06-30 | $25.46B | $23.64B | 1.08 |
| 2021-03-31 | $24.44B | $22.28B | 1.10 |
| 2020-12-31 | $23.39B | $21.59B | 1.08 |
| 2020-09-30 | $27.28B | $21.80B | 1.25 |
| 2020-06-30 | $26.82B | $21.92B | 1.22 |
| 2020-03-31 | $24.70B | $21.65B | 1.14 |
| 2019-12-31 | $20.32B | $12.93B | 1.57 |
| 2019-09-30 | $13.46B | $13.28B | 1.01 |
| 2019-06-30 | $13.60B | $12.65B | 1.08 |
| 2019-03-31 | $13.62B | $13.14B | 1.04 |
| 2018-12-31 | $12.00B | $11.97B | 1.00 |
| 2018-09-30 | $13.09B | $12.74B | 1.03 |
| 2018-06-30 | $12.38B | $9.86B | 1.26 |
| 2018-03-31 | $10.98B | $10.89B | 1.01 |
| 2017-12-31 | $8.70B | $9.33B | 0.93 |
| 2017-09-30 | $9.66B | $9.71B | 1.00 |
| 2017-06-30 | $9.65B | $8.97B | 1.08 |
| 2017-03-31 | $9.41B | $9.20B | 1.02 |
| 2016-12-31 | $8.37B | $8.62B | 0.97 |
| 2016-09-30 | $7.76B | $9.02B | 0.86 |
| 2016-06-30 | $7.85B | $8.81B | 0.89 |
| 2016-03-31 | $7.55B | $7.87B | 0.96 |
| 2015-12-31 | $3.61B | $3.63B | 0.99 |
| 2015-09-30 | $3.60B | $3.56B | 1.01 |
| 2015-06-30 | $3.84B | $3.46B | 1.11 |
| 2015-03-31 | $3.59B | $3.34B | 1.07 |
| 2014-12-31 | $2.95B | $2.90B | 1.02 |
| 2014-09-30 | $2.77B | $2.63B | 1.05 |
| 2014-06-30 | $2.33B | $2.12B | 1.10 |
| 2014-03-31 | $2.28B | $2.02B | 1.13 |
| 2013-12-31 | $1.80B | $1.56B | 1.16 |
| 2013-09-30 | $1.37B | $1.39B | 0.99 |
| 2013-06-30 | $1.34B | $1.32B | 1.02 |
| 2013-03-31 | $1.38B | $1.31B | 1.05 |
| 2012-12-31 | $1.41B | $1.23B | 1.14 |
| 2012-09-30 | $1.38B | $1.28B | 1.08 |
| 2012-06-30 | $1.07B | $1.03B | 1.04 |
| 2012-03-31 | $0.92B | $0.89B | 1.04 |
| 2011-12-31 | $0.94B | $0.84B | 1.12 |
| 2011-09-30 | $0.77B | $0.73B | 1.05 |
| 2011-06-30 | $0.78B | $0.75B | 1.03 |
| 2011-03-31 | $0.74B | $0.82B | 0.91 |
| 2010-12-31 | $0.66B | $0.77B | 0.86 |
| 2010-09-30 | $0.68B | $0.66B | 1.02 |
| 2010-06-30 | $0.55B | $0.64B | 0.86 |
| 2010-03-31 | $0.57B | $0.69B | 0.84 |
| 2009-12-31 | $0.62B | $0.72B | 0.86 |
| 2009-09-30 | $0.61B | $0.71B | 0.87 |
| 2009-06-30 | $0.69B | $0.66B | 1.03 |
| 2009-03-31 | $0.64B | $0.68B | 0.94 |
| 2008-12-31 | $0.67B | $0.64B | 1.04 |
| 2008-09-30 | $0.63B | $0.60B | 1.06 |
| 2008-06-30 | $0.58B | $0.52B | 1.12 |
| 2008-03-31 | $0.44B | $0.47B | 0.95 |
| 2007-12-31 | $0.45B | $0.49B | 0.92 |
| 2007-09-30 | $0.45B | $0.47B | 0.97 |
| 2007-06-30 | $0.44B | $0.45B | 0.98 |
| 2007-03-31 | $0.48B | $0.39B | 1.23 |
| 2006-12-31 | $0.45B | $0.39B | 1.17 |
| 2006-09-30 | $0.38B | $0.33B | 1.12 |
| 2006-06-30 | $0.33B | $0.26B | 1.27 |
| 2006-03-31 | $0.28B | $0.24B | 1.20 |
| 2005-12-31 | $0.27B | $0.22B | 1.27 |
| 2005-09-30 | $0.24B | $0.21B | 1.17 |
| 2005-06-30 | $0.22B | $0.20B | 1.12 |
| 2005-03-31 | $0.25B | $0.22B | 1.12 |
| 2004-12-31 | $0.22B | $0.20B | 1.11 |
| 2004-09-30 | $0.17B | $0.15B | 1.12 |
| 2004-06-30 | $0.15B | $0.14B | 1.08 |
| 2004-03-31 | $0.11B | $0.13B | 0.84 |
| 2003-12-31 | $0.11B | $0.13B | 0.86 |
| 2003-09-30 | $0.10B | $0.11B | 0.97 |
| 2003-06-30 | $0.08B | $0.10B | 0.80 |
| 2003-03-31 | $0.10B | $0.11B | 0.89 |
| 2002-12-31 | $0.09B | $0.10B | 0.91 |
| 2002-09-30 | $0.08B | $0.07B | 1.12 |
| 2002-06-30 | $0.07B | $0.07B | 0.96 |
| 2002-03-31 | $0.11B | $0.07B | 1.58 |
| 2001-12-31 | $0.10B | $0.07B | 1.54 |
| 2001-09-30 | $0.00B | 0.00 | |
| 2001-06-30 | $0.00B | 0.00 | |
| 2001-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $18.343B | $194.777B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Humana (HUM) | United States | $23.068B | 11.22 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |